RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5542
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Name tag: GFP
Transgene
Transgene Plasmodium: Gene model: PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Promoter: Gene model: PBANKA_0501200; Gene model (P.falciparum): PF3D7_1016900; Gene product: early transcribed membrane protein 10.3 | protein of early gametocyte 4 (UIS4; ETRAMP10.3)
3'UTR: Gene model: PBANKA_0403200; Gene product: circumsporozoite (CS) protein (CSP)
Insertion locus: Gene model: Not available; Gene product: Not available
Phenotype Sporozoite;
Last modified: 11 September 2024, 14:06
  *RMgm-5542
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 38396332
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherThieleke-Matos C, Frischknecht F,Singer M
Name Group/DepartmentIntegrative Parasitology, Center for Infectious Diseases
Name InstituteHeidelberg University Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-5542
Principal nameUis4-TSR- GFP- CSP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteHigh numbers of salivary gland-derived fluorescent sporozoites are produced, but their fluorescence was weak and variable.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a GFP-tagged version of CSP. The GFP-tagged csp gene is under control of the uis4 (PBANKA_0501200) promoter (and with a shortened 3'UTR of csp) and is introduced in a locus on chromosome 12 between the genes PBANKA_122210 and PBANKA_122220.

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
High numbers of salivary gland-derived fluorescent sporozoites are produced, but their fluorescence was weak and variable.

To investigate CSP function by live fluorescence microscopy, we recently generated a series of P. berghei parasites expressing internally tagged CSP-GFP fusion proteins (Singer & Frischknecht, 2021; see mutants RMgm-4901). A replacement of CSP with a CSP-GFP fusion where the GFP was inserted between the signal peptide and the N-terminus allowed sporozoite formation. However, sporozoites degenerated within the cysts, and the CSP-GFP fusion was not detectable at the plasma membrane but within internal membranes suggesting processing of the protein shortly after the fusion protein was made. In contrast, two other internally tagged proteins allowed CSP-GFP expression and correct plasma membrane localization, albeit they were only expressed as additional copies from the csp locus. In these parasite lines, the GFP was inserted between either the repeats and the TSR (R-GFP-CSP) or the TSR and the GPI anchor (TSR-GFP-CSP). This allowed full sporozoite formation and targeted the protein to the plasma membrane. Yet, these parasites failed to egress from oocysts (Singer & Frischknecht, 2021; see mutants RMgm-4901).

Here, we sought to explore different strategies to overcome this block in sporozoite egress from oocysts. First, we generated a parasite line, where the N-terminus and the repeats were replaced by GFP. This parasite line did not form sporozoites. Second, we generated a parasite line with decreased expression of an internally tagged CSP-GFP. This allowed sporozoite formation but the sporozoites did not egress. Third, we crossed egress-deficient CSP-GFP parasite lines with wild-type parasites. This allowed sporozoite egress and yielded low numbers of fluorescent salivary gland sporozoites. Lastly, we explored a strategy of expressing an additional copy of CSP-GFP from a silent locus and two promoters that are only active upon salivary gland entry, uis4 (PBANKA_0501200) and spect2 (PBANKA_1006300). This gave high numbers of salivary gland-derived fluorescent sporozoites, but their fluorescence was weak.

Additional information

Other mutants

 


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Name of the tagGFP
Details of taggingC-terminal
Additional remarks: taggingThe mutant expresses a GFP-tagged version of CSP. The GFP-tagged csp gene is under control of the uis4 (PBANKA_0501200) promoter and is introduced in a locus on chromosome 12 between the genes PBANKA_122210 and PBANKA_122220.
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate the vector for GFP-TSR rplc, the 3′ UTR of CSP used for integration was amplified with P278 P279, digested with HindIII KpnI and cloned into Pb238. The promoter region of CSP including the SP was amplified with P208 P268, digested with EcoRI and PshAI and ligated into the vector. Then, the GPI-anchored sequence including the 3′ UTR was amplified with P274 P576, digested with KasI BamHI and ligated into the vector. Prior to transfection the vector was linearized using PmeI and EcoRI. Genotyping was performed with P267 P210 (for 5′ UTR) resulting in 1298 bp, 3′ integration with P234 P882 resulting in 1187 bp and the whole locus PCR resulting in 6044 bp as well as 3051 bp for WT.

For the generation of the R-GFP-CSP replacement construct, the downstream homology region in the extended 3′ untranslated region of CSP was amplified using the primers KW-39 and KW-36 from PbANKA genomic DNA. The fragment was integrated by digest and ligation with HindIII and XhoI into the previously established plasmid containing the R-GFP-CSP construct. The plasmid was digested with EcoRI and XhoI and integrated via homologous recombination, replacing the endogenous CSP. Alternative homologous recombination of the same construct allowed for the generation of the CSP Ctrl. rplc parasite line. Genotyping of 5′ integration and 3′ integration was confirmed through PCR amplification with the primers KW-60 with P210 and P187 with KW-61, respectively. The whole-length fragment is amplified with primers KW-60 and KW-61.

Promoter-swapped TSR-GFP-CSP constructs were generated by amplification of the spect2 and uis4 5′ promoter regions with the primers Spect2-GA1 and Spect2-GA3 and GA1 and GA3, respectively. An additional fragment was amplified spanning the N-terminal CSP region and GFP with the primers Spect2-GA2 and GA4 for the Spect2-TSR-CSP-GFP construct and the primers GA2 and GA4 for the UIS4-TSR-CSP-GFP construct. The previously established TSR-GFP-CSP containing plasmid was digested using EcoRI and PvuII. The fragments were integrated into the vector backbone (NEBuilder Hifi DNA assembly). The plasmid was digested with PvuI and integrated via homologous recombination in a silent genomic region on chromosome 12. 5′ integration and 3′ integration were confirmed through PCR amplification with the primers P135 with P210 and P135 with P137, respectively. The whole-length fragment is amplified using P134 and P137. T Prior to transfection, the correct sequence of all plasmids was confirmed via Sanger sequencing
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: Plasmodium
Gene Model of Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate the vector for GFP-TSR rplc, the 3′ UTR of CSP used for integration was amplified with P278 P279, digested with HindIII KpnI and cloned into Pb238. The promoter region of CSP including the SP was amplified with P208 P268, digested with EcoRI and PshAI and ligated into the vector. Then, the GPI-anchored sequence including the 3′ UTR was amplified with P274 P576, digested with KasI BamHI and ligated into the vector. Prior to transfection the vector was linearized using PmeI and EcoRI. Genotyping was performed with P267 P210 (for 5′ UTR) resulting in 1298 bp, 3′ integration with P234 P882 resulting in 1187 bp and the whole locus PCR resulting in 6044 bp as well as 3051 bp for WT.

For the generation of the R-GFP-CSP replacement construct, the downstream homology region in the extended 3′ untranslated region of CSP was amplified using the primers KW-39 and KW-36 from PbANKA genomic DNA. The fragment was integrated by digest and ligation with HindIII and XhoI into the previously established plasmid containing the R-GFP-CSP construct. The plasmid was digested with EcoRI and XhoI and integrated via homologous recombination, replacing the endogenous CSP. Alternative homologous recombination of the same construct allowed for the generation of the CSP Ctrl. rplc parasite line. Genotyping of 5′ integration and 3′ integration was confirmed through PCR amplification with the primers KW-60 with P210 and P187 with KW-61, respectively. The whole-length fragment is amplified with primers KW-60 and KW-61.

Promoter-swapped TSR-GFP-CSP constructs were generated by amplification of the spect2 and uis4 5′ promoter regions with the primers Spect2-GA1 and Spect2-GA3 and GA1 and GA3, respectively. An additional fragment was amplified spanning the N-terminal CSP region and GFP with the primers Spect2-GA2 and GA4 for the Spect2-TSR-CSP-GFP construct and the primers GA2 and GA4 for the UIS4-TSR-CSP-GFP construct. The previously established TSR-GFP-CSP containing plasmid was digested using EcoRI and PvuII. The fragments were integrated into the vector backbone (NEBuilder Hifi DNA assembly). The plasmid was digested with PvuI and integrated via homologous recombination in a silent genomic region on chromosome 12. 5′ integration and 3′ integration were confirmed through PCR amplification with the primers P135 with P210 and P135 with P137, respectively. The whole-length fragment is amplified using P134 and P137. T Prior to transfection, the correct sequence of all plasmids was confirmed via Sanger sequencing
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0501200
Gene Model P. falciparum ortholog PF3D7_1016900
Gene productearly transcribed membrane protein 10.3 | protein of early gametocyte 4
Gene product: Alternative nameUIS4; ETRAMP10.3
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0403200
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4